OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 23-49
Open Access | Times Cited: 15
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 23-49
Open Access | Times Cited: 15
Showing 15 citing articles:
Drugs for COVID-19: An Update
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
Chronic Obstructive Pulmonary Disease and COVID-19: The Impact of Hematological Biomarkers on Disease Severity and Outcomes
G Mara, Gheorghe Nini, Coralia Cotoraci
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2765-2765
Open Access
G Mara, Gheorghe Nini, Coralia Cotoraci
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2765-2765
Open Access
Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1238-1254
Open Access | Times Cited: 17
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1238-1254
Open Access | Times Cited: 17
The critical impacts of cytokine storms in respiratory disorders
Shahana Riyaz Tramboo, Ahmed M. E. Elkhalifa, Syed Quibtiya, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29769-e29769
Open Access | Times Cited: 2
Shahana Riyaz Tramboo, Ahmed M. E. Elkhalifa, Syed Quibtiya, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29769-e29769
Open Access | Times Cited: 2
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials
Qinglin Cheng, Gang Zhao, Chen Jun-fang, et al.
Medicine (2022) Vol. 101, Iss. 41, pp. e30998-e30998
Open Access | Times Cited: 9
Qinglin Cheng, Gang Zhao, Chen Jun-fang, et al.
Medicine (2022) Vol. 101, Iss. 41, pp. e30998-e30998
Open Access | Times Cited: 9
Bilateral Shoulder Infections and Delayed Recognition of Spinal Discitis in an Adult Male With Mild COVID-19 and Staphylococcus aureus Bacteremia: Case Report and Literature Review
John G. Skedros, Jessie A Montgomery, John T Cronin, et al.
Cureus (2024)
Open Access
John G. Skedros, Jessie A Montgomery, John T Cronin, et al.
Cureus (2024)
Open Access
Early taurine administration as a means for halting the cytokine storm progression in COVID-19 patients
Alberto Rubio‐Casillas, Ramesh C. Gupta, Elrashdy M. Redwa, et al.
Exploration of Medicine (2022), pp. 234-248
Open Access | Times Cited: 2
Alberto Rubio‐Casillas, Ramesh C. Gupta, Elrashdy M. Redwa, et al.
Exploration of Medicine (2022), pp. 234-248
Open Access | Times Cited: 2
Experience of tocilizumab in hospital patients with moderate COVID-19
OA Burgasova, SV Dolinniy, V.B. Tetova, et al.
Bulletin of Russian State Medical University (2022), Iss. 2022(2)
Open Access | Times Cited: 1
OA Burgasova, SV Dolinniy, V.B. Tetova, et al.
Bulletin of Russian State Medical University (2022), Iss. 2022(2)
Open Access | Times Cited: 1
A strategy to develop one step real-time RT-PCR for diagnosis of SARS-CoV-2 infection from clinical samples
Arbind Kumar, Arun Kumar, Yogendra Padwad, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Arbind Kumar, Arun Kumar, Yogendra Padwad, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Surveillance of omicron variant in Kangra District of Himachal Pradesh, India during the 3rd disease wave of COVID-19
Suresh Kumar, Sahdev Choudhary, Sharad Thakur, et al.
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 04, pp. 448-453
Open Access
Suresh Kumar, Sahdev Choudhary, Sharad Thakur, et al.
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 04, pp. 448-453
Open Access
Assessment of Traces of SARS-CoV-2 RNA in a Laboratory Setting Using In vitro-Diagnostic RT-qPCR
Suresh Kumar, Lal Chand Pal, Sahdev Choudhary, et al.
Coronaviruses (2023) Vol. 4, Iss. 2
Closed Access
Suresh Kumar, Lal Chand Pal, Sahdev Choudhary, et al.
Coronaviruses (2023) Vol. 4, Iss. 2
Closed Access
Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients
Ana Paula Velez, Guy Handley, Austin Morison, et al.
Cancer Control (2023) Vol. 30
Open Access
Ana Paula Velez, Guy Handley, Austin Morison, et al.
Cancer Control (2023) Vol. 30
Open Access
Soboleva Av, Vorobyev Po, Vasilenko Kv, et al.
Вестник Российского государственного медицинского университета (2022), Iss. 2022(2)
Open Access
Opyt primeneniya tocilizumaba u stacionarnyh pacientov so srednetyazhelym techeniem COVID-19
O. Burgasova, Sergei Vladimirovich Dolinnyi, В. Б. Тетова, et al.
Вестник Российского государственного медицинского университета (2022), Iss. 2022(2)
Open Access
O. Burgasova, Sergei Vladimirovich Dolinnyi, В. Б. Тетова, et al.
Вестник Российского государственного медицинского университета (2022), Iss. 2022(2)
Open Access
